Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7851170 Modified cell for production of grampositive specific immunoglobulins
12/14/2010US7851168 Using 7a5/prognostin expresion profile to diagnose/prognose colon cancer
12/14/2010US7851166 Method for detecting mycobacterial infection
12/14/2010US7850980 Chlamydia OMP antigen
12/14/2010US7850979 Generating lymphocytes immune response; vector gene expression ; induction lymphocyte response against antigen using adenovirus vector; antiulcer agents; inflammatory bowel disorders; autoimmune diseases; anticancer agenst
12/14/2010US7850978 Vaccine against feline calicivirus
12/14/2010US7850977 contain alphavirus 5' and alphavirus 3' replication recognition sequences and a nucleotide sequence encoding an alphavirus structural protein; alphavirus replicon particles useful as immunostimulants
12/14/2010US7850976 Insulin resistance improving agents
12/14/2010US7850975 Chemically programmable immunity
12/14/2010US7850974 Using sequences infomation to identify microbial surface components recognizing adhesive matrix molecules (MSCRAMM proteins) in order to diagnose, treat and prevent bacterial infection
12/14/2010US7850973 Amino acid composition comprising a multivalent branched multiple antigen peptide (MAP) linked to a carrier for induction of immune response to amyloid beta deposition in brain; treatment and prevention of nervous system disorders
12/14/2010US7850972 Immunogenic cryptosporidium parvum polypeptide for use in treatment and prevention of protozoal infection
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850970 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax
12/14/2010US7850969 Apparatus for reducing secretory activity of leukocytes which comprises plastic housing, carriers, blood inlet/outlet nozzles and an antibody against Fas (CD95) that is linked to the carrier
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850967 Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BAFFR
12/14/2010US7850966 Method of treating breast cancer using anti-HER2 antibody variants
12/14/2010US7850965 Anti-orthopoxvirus recombinant polyclonal antibody
12/14/2010US7850964 Using bone morphogenic protein-1 specific immunoglobulin for treatment of chronic renal failure
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010US7850962 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
12/14/2010US7850961 Mammary gland tumor cell for use as model in screening cell proliferative disorders
12/14/2010US7850958 Recombinant double stranded RNA nucleocapsid and use of the same
12/14/2010US7850957 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
12/14/2010US7850956 Immunization by inoculation of DNA transcription unit
12/14/2010CA2504755C Carbohydrate-based synthetic vaccines for hiv
12/14/2010CA2394946C Method of inactivating microorganisms
12/14/2010CA2365392C Vaccine preparation containing fatty acid as a constituent
12/14/2010CA2351010C A broad spectrum infectious bursal disease virus vaccine
12/14/2010CA2247989C C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses
12/14/2010CA2238659C Recombinant birnavirus vaccine
12/14/2010CA2205007C Antibody against human interleukin-5 receptor .alpha. chain
12/14/2010CA2171942C Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
12/14/2010CA2152917C Liposome with oligosaccharide on surface
12/09/2010WO2010141710A2 Antibodies that bind selectively to p25 and uses therefor
12/09/2010WO2010141658A1 Therapeutic compositions and methods for the prevention of autoimmune diseases
12/09/2010WO2010141630A1 Compositions and methods for treatment of cancer by disrupting the lh/lhr signaling pathway
12/09/2010WO2010141566A1 Conjugation methods
12/09/2010WO2010141483A2 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9
12/09/2010WO2010141143A2 Engineered avirulent bacteria strains and use in medical treatments
12/09/2010WO2010141093A2 Co-signaling methods for treating cancers
12/09/2010WO2010141084A2 Recombinant subunit west nile virus vaccine for protections of human subjects
12/09/2010WO2010140973A1 Recombinantly produced allergens
12/09/2010WO2010140694A1 Method for screening of inhibitor using factor capable of enhancing production of amyloid-beta peptide, and inhibitor obtained by same
12/09/2010WO2010140377A1 Vaccine for mycoplasma infection
12/09/2010WO2010140119A1 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES
12/09/2010WO2010140114A1 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine -origin influenza a (h1n1) virus (s-oiv) infections
12/09/2010WO2010139809A1 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
12/09/2010WO2010139742A1 TREATMENT OF ONCOSTATIN M RECEPTOR β MEDIATED HEART FAILURE
12/09/2010WO2010139196A1 Human anti human interferon alpha antibody and use thereof
12/09/2010WO2010139193A1 Hand-foot-mouth disease vaccine, preparation method and uses thereof
12/09/2010WO2010139047A1 Reagents and methods for detecting influenza virus proteins
12/09/2010WO2010124276A9 Anti-tgf-beta induction of bone cell function and bone growth
12/09/2010WO2010090873A3 Polypeptides and their use as adjuvants
12/09/2010WO2010088491A3 Methods of monitoring treatment of aviremic hiv-infected patients
12/09/2010WO2010085358A3 Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
12/09/2010WO2010062396A3 Virus like particle compositions and methods of use
12/09/2010US20100313298 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine
12/09/2010US20100313285 Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation
12/09/2010US20100313284 Means and methods for eliciting an immune response
12/09/2010US20100313283 Uses of gdnf and gdnf receptor
12/09/2010US20100312312 Method for selective photodynamic therapy and light source for implementation thereof
12/09/2010US20100311120 Human cytokine receptor
12/09/2010US20100311105 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/09/2010US20100311088 Recombinant antigens for diagnosis and prevention of murine typhus
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100311054 Compositions and Methods for the Detection of Human T Cell Receptor Variable Family Gene Expression
12/09/2010US20100311050 Compositions and methods for the diagnosis and treatment of tumor
12/09/2010US20100310656 Immunotherapy and prevention of autoimmune hepatitis
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310643 Cd133 epitopes
12/09/2010US20100310641 Therapeutic approaches for treating cmt and related disorders
12/09/2010US20100310640 Hla-dr binding peptides and their uses
12/09/2010US20100310639 Immuno-modulatory composition
12/09/2010US20100310638 Liposomes comprising duramycin and anti-viral agents
12/09/2010US20100310637 Composition and method for the treatment or prevention of glaucoma and ocular hypertension
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310606 Vaccination with killed but metabolically active (kbma) protozoans with toll-like receptor agonists
12/09/2010US20100310605 anti-hcv vaccine and preparation methods and uses thereof
12/09/2010US20100310604 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
12/09/2010US20100310603 TEM8 as an Adjuvant and Uses Thereof
12/09/2010US20100310602 Synthetic glucopyranosyl lipid adjuvants
12/09/2010US20100310601 Adeno-Associated Virus Materials and Methods
12/09/2010US20100310600 Selective agonist of toll-like receptor 3
12/09/2010US20100310597 Anti-ofloxacin monoclonal antibody and immunoassay of ofloxacin using the same
12/09/2010US20100310596 Method and Compositions for Cutaneous Immunisation
12/09/2010US20100310595 Method of transfection and compositions therefor
12/09/2010US20100310594 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
12/09/2010US20100310593 Vaccines Against Chlamydia Infection
12/09/2010US20100310592 A truncated form of the hiv p17 protein
12/09/2010US20100310591 Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA
12/09/2010US20100310590 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/09/2010US20100310589 Swine vaccination system
12/09/2010US20100310588 Regulatory t cells suppress autoimmunity
12/09/2010US20100310587 Immunomodulatory compositions
12/09/2010US20100310586 Idiotypic vaccine
12/09/2010US20100310585 The use of monomycolyl glycerol (mmg) as an adjuvant
12/09/2010US20100310584 Antigen
1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 1823